Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral neuropeptide Y receptor Y5 (NPY5R) antagonist
Molecular Target Neuropeptide Y receptor Y5 (NPY5R)
Mechanism of ActionNeuropeptide Y receptor Y5 (NPY5R) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today